TILRAY INC-CLASS 2 COMMON

Tilray Inc is a Canadian pharmaceutical company specialising in the production of cannabis. It has offices in Australia, New Zealand, Germany, Portugal and Latin America.

In December 2020, the company announced a merger with Aphria.

In 2018, Tilray Inc went public on the NASDAQ and Toronto exchanges, becoming the only publicly traded cannabis company. On the first day of trading, the shares price was $17, then after a few months, their value increased to $214 and then dropped again to $29 by August 2019.

Traders deservedly consider this stock one of the most visible on the market due to its volatility and unpredictability. At the same time, it will be quite difficult for beginners to keep up with Tilray Inc. However, if you understand the general correlations and monitor how the chart reacts to certain news, you may be able to make effective trades. You can not only buy but sell this asset as well, thanks to the CFD format.

You can see Bid and Ask online prices in real-time on this page. However, the most accurate quotes are waiting for you in trading terminals.

Please note that in the case companies issue a dividend, the ex-dividend date, that is the date without entitlement to the dividend, is known in advance and is displayed in the corresponding calendar on our website. If you have a Buy position open on the ex-dividend date, your trading account will be credited with the dividend net of any withholding taxes. In the case of holding a Sell position, the whole dividend will be debited to your account. If you have questions about this, our customer support team are on hand to assist.

Start Trading TLRY.O CFD Stocks with FxPro Today!